Physician

Aliya Sakinah Hayes, MD

According to 2025 Medicare claims, Aliya Hayes, MD (NPI: 1194902130) practices endocrinology in the Houston-Pasadena-The Woodlands, TX market, with the plurality of this provider's patient population coming from Harris, TX. This provider's primary affiliated billing organization is PRIVIA MEDICAL GROUP GULF COAST, PLLC (NPI: 1578969465; TIN: 462456505) and primary practice location at 77504-1929. Hayes is affiliated with the Privia Quality Network Gulf Coast II, LLC (ACO ID: A3783), participating under the MSSP model.

Hayes' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 225 traditional Medicare patients, billed 2,268 HCPCS/CPT codes, and received $62,051 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,960 prescription claims across 450 beneficiaries totaling $1,804,297 in drug costs, led by Ozempic (Semaglutide). DME data shows 409 claims. Open Payments data shows 107 records totaling $2,103. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $883,194 to $1,804,297. For DME billing, reported payments rose steadily, from $1,045 to $110,307.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	175	2,443	$76,739
2016	199	2,608	$72,043
2017	235	1,140	$38,829
2018	148	1,503	$44,649
2019	205	1,778	$53,776
2020	199	994	$33,543
2021	204	980	$51,734
2022	213	2,195	$65,692
2023	221	2,510	$72,327
2024	225	2,268	$62,051

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	358	2,808	$883,194
2016	425	3,869	$1,361,124
2017	440	3,186	$1,283,932
2018	257	2,309	$939,022
2019	300	3,050	$1,256,527
2020	334	3,438	$1,441,456
2021	350	3,634	$1,738,603
2022	365	3,256	$1,514,559
2023	401	3,377	$1,871,951
2024	450	3,960	$1,804,297

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	148	257	$5,476
2016	151	320	$6,666
2017	113	269	$8,078
2018	76	186	$13,644
2019	82	295	$40,538
2020	98	344	$42,015
2021	105	401	$53,883
2022	90	368	$50,818
2023	105	412	$62,294
2024	104	409	$109,544

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	145	261	$79
80061	Blood test, lipids (cholesterol and triglycerides)	139	252	$13
80053	Blood test, comprehensive group of blood chemicals	151	268	$10
83036	Hemoglobin a1c level	135	246	$9
82962	Blood glucose (sugar) test performed by hand-held instrument	163	312	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	183	10,938	$344,055
Mounjaro	Tirzepatide	111	4,050	$146,386
Tresiba Flextouch U-200	Insulin Degludec	87	6,439	$127,464
Jardiance	Empagliflozin	78	6,180	$116,577
Trulicity	Dulaglutide	63	3,090	$99,600

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	46	231	$88,361
E0784	External ambulatory infusion pump, insulin	Y	N/R	25	$8,286
J1817	Insulin for administration through dme (i.e., insulin pump) per 50 units	N	N/R	12	$4,150
A4224	Supplies for maintenance of insulin infusion catheter, per week	N	N/R	13	$3,145
E2103	Non-adjunctive, non-implanted continuous glucose monitor or receiver	N	14	14	$3,027

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	107	$2,103	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Aliya Sakinah Hayes, MD?

Tedicare shows public-source Medicare data for Aliya Sakinah Hayes, MD (NPI 1194902130), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aliya Sakinah Hayes, MD have ACO affiliation data?

Aliya Sakinah Hayes, MD is shown with ACO affiliation data for Privia Quality Network Gulf Coast II, LLC (MSSP, ACO ID A3783).

What billing organization is linked to Aliya Sakinah Hayes, MD?

Aliya Sakinah Hayes, MD is linked to PRIVIA MEDICAL GROUP GULF COAST, PLLC (billing NPI 1578969465) in the available physician profile data.

Does Aliya Sakinah Hayes, MD have Open Payments data?

Aliya Sakinah Hayes, MD has 107 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.